News
Huntington's Disease Treatment Market to Hit $2.03 Billion by 2033, Driven by Cutting-Edge Therapies
Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Huntington's Disease Treatment Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets ...
11don MSN
The number of people who have the gene that causes Huntington's disease in Northern Scotland has been accurately counted for ...
Hosted on MSN27d
Beta-Blockers Tied to Delayed Huntington's Disease Progression"Patients with Huntington's disease are known to have imbalances ... MD of 0.10 points Symbol digit modalities test: MD of 0.33 points Post hoc analyses did not show significant beneficial effects ...
One of the areas of the brain where these cells congregate is the ventricular zone, which is adjacent to the striatum, a region of the brain devastated by Huntington's disease. The idea that the ...
The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating Huntington's disease, a rare neurodegenerative condition. This designation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback